HEADER TRANSFERASE 20-DEC-18 6IZQ TITLE PRMT4 BOUND WITH A BICYCLIC COMPOUND COMPND MOL_ID: 1; COMPND 2 MOLECULE: HISTONE-ARGININE METHYLTRANSFERASE CARM1; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: COACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1,PROTEIN COMPND 5 ARGININE N-METHYLTRANSFERASE 4; COMPND 6 EC: 2.1.1.319; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CARM1, PRMT4; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HISTONE-ARGININE METHYLTRANSFERASE CARM1, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR B.XIONG,D.Y.CAO,Z.H.GUO,Y.L.LI,J.LI,X.HUANG,J.K.SHEN REVDAT 2 27-MAR-24 6IZQ 1 REMARK REVDAT 1 25-DEC-19 6IZQ 0 JRNL AUTH Z.GUO,Z.ZHANG,H.YANG,D.CAO,X.XU,X.ZHENG,D.CHEN,Q.WANG,Y.LI, JRNL AUTH 2 J.LI,Z.DU,X.WANG,L.CHEN,J.DING,J.SHEN,M.GENG,X.HUANG,B.XIONG JRNL TITL DESIGN AND SYNTHESIS OF POTENT, SELECTIVE INHIBITORS OF JRNL TITL 2 PROTEIN ARGININE METHYLTRANSFERASE 4 AGAINST ACUTE MYELOID JRNL TITL 3 LEUKEMIA. JRNL REF J.MED.CHEM. V. 62 5414 2019 JRNL REFN ISSN 0022-2623 JRNL PMID 31117515 JRNL DOI 10.1021/ACS.JMEDCHEM.9B00297 REMARK 2 REMARK 2 RESOLUTION. 2.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.11.1_2575: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 89.24 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 56632 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.530 REMARK 3 FREE R VALUE TEST SET COUNT : 1997 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 89.2995 - 5.9025 0.98 4136 151 0.1947 0.2197 REMARK 3 2 5.9025 - 4.6850 1.00 4021 147 0.1713 0.2279 REMARK 3 3 4.6850 - 4.0928 1.00 3985 145 0.1569 0.1991 REMARK 3 4 4.0928 - 3.7186 0.99 3947 144 0.1798 0.2189 REMARK 3 5 3.7186 - 3.4521 0.89 3491 128 0.1901 0.2549 REMARK 3 6 3.4521 - 3.2485 1.00 3909 143 0.2063 0.2673 REMARK 3 7 3.2485 - 3.0858 1.00 3941 144 0.2205 0.2931 REMARK 3 8 3.0858 - 2.9515 1.00 3911 143 0.2190 0.3104 REMARK 3 9 2.9515 - 2.8379 1.00 3881 142 0.2198 0.3038 REMARK 3 10 2.8379 - 2.7399 1.00 3890 142 0.2067 0.2928 REMARK 3 11 2.7399 - 2.6543 1.00 3883 142 0.2085 0.2753 REMARK 3 12 2.6543 - 2.5784 0.99 3849 141 0.2017 0.2612 REMARK 3 13 2.5784 - 2.5105 0.99 3905 143 0.1998 0.3084 REMARK 3 14 2.5105 - 2.4492 0.99 3886 142 0.1985 0.2955 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.300 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.620 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 10844 REMARK 3 ANGLE : 0.900 14712 REMARK 3 CHIRALITY : 0.053 1617 REMARK 3 PLANARITY : 0.006 1882 REMARK 3 DIHEDRAL : 3.309 6366 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6IZQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 10-JAN-19. REMARK 100 THE DEPOSITION ID IS D_1300010216. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-NOV-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97923 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56632 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.449 REMARK 200 RESOLUTION RANGE LOW (A) : 89.240 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.50 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: HKL-3000 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.37 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 22-27% PEG 3350, 0.15M SODIUM MALATE, REMARK 280 PH 7.0, EVAPORATION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 37.39400 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 49.46300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 37.39400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 49.46300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: OCTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 23150 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 95800 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -134.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 98.92600 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 477 REMARK 465 SER B 145 REMARK 465 ALA B 146 REMARK 465 THR B 477 REMARK 465 SER D 145 REMARK 465 TYR D 476 REMARK 465 THR D 477 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 363 CG CD CE NZ REMARK 470 ARG B 174 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 184 CG CD CE NZ REMARK 470 LYS B 227 CG CD CE NZ REMARK 470 LYS B 351 CG CD CE NZ REMARK 470 LYS B 375 CG CD CE NZ REMARK 470 LYS B 444 CG CD CE NZ REMARK 470 LYS B 462 CG CD CE NZ REMARK 470 ASN B 471 CG OD1 ND2 REMARK 470 GLN C 148 CG CD OE1 NE2 REMARK 470 TYR C 314 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG C 327 CG CD NE CZ NH1 NH2 REMARK 470 LYS C 351 CG CD CE NZ REMARK 470 THR C 477 CA C O CB OG1 CG2 REMARK 470 ARG D 208 CG CD NE CZ NH1 NH2 REMARK 470 TYR D 314 CG CD1 CD2 CE1 CE2 CZ OH REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LEU D 421 ND2 ASN D 465 1.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU D 294 CA - CB - CG ANGL. DEV. = 14.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 184 107.34 -58.04 REMARK 500 LEU A 263 -56.32 73.61 REMARK 500 GLU A 266 -11.13 88.04 REMARK 500 ASP A 299 85.05 -162.12 REMARK 500 SER A 317 67.44 -154.61 REMARK 500 ASP A 341 165.79 179.30 REMARK 500 TYR A 416 -139.36 47.14 REMARK 500 SER A 447 -158.12 -150.97 REMARK 500 ASN A 471 62.79 -117.22 REMARK 500 ASN B 179 54.24 -109.20 REMARK 500 LEU B 263 -50.01 69.81 REMARK 500 GLU B 266 -10.92 79.44 REMARK 500 ASP B 299 86.76 -152.12 REMARK 500 SER B 317 67.60 -150.91 REMARK 500 ASP B 341 -171.48 -174.28 REMARK 500 TYR B 416 -140.07 48.12 REMARK 500 SER B 447 -153.45 -142.48 REMARK 500 ASN B 471 63.42 -117.72 REMARK 500 LEU C 263 -49.78 68.21 REMARK 500 GLU C 266 -3.29 81.30 REMARK 500 ASP C 299 85.74 -165.61 REMARK 500 ASP C 341 -173.08 -175.19 REMARK 500 TYR C 416 -136.39 48.40 REMARK 500 SER C 447 -156.81 -147.88 REMARK 500 LEU C 469 -7.30 -59.50 REMARK 500 ASN D 179 44.95 -108.80 REMARK 500 LEU D 263 -50.58 72.45 REMARK 500 GLU D 266 -22.09 82.80 REMARK 500 ASP D 299 82.44 -158.46 REMARK 500 SER D 317 67.73 -151.26 REMARK 500 VAL D 321 -122.90 10.06 REMARK 500 ASP D 322 63.82 37.49 REMARK 500 LEU D 323 106.43 -59.64 REMARK 500 LEU D 326 39.92 -69.46 REMARK 500 MET D 400 145.78 -170.28 REMARK 500 TYR D 416 -134.17 46.30 REMARK 500 ARG D 445 30.38 -89.40 REMARK 500 SER D 447 -151.18 -142.22 REMARK 500 SER D 464 -169.60 -118.68 REMARK 500 ASN D 465 145.46 171.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASP D 322 LEU D 323 149.58 REMARK 500 ARG D 327 GLY D 328 137.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue XJ2 A 501 DBREF 6IZQ A 145 477 UNP Q86X55 CARM1_HUMAN 145 477 DBREF 6IZQ B 145 477 UNP Q86X55 CARM1_HUMAN 145 477 DBREF 6IZQ C 145 477 UNP Q86X55 CARM1_HUMAN 145 477 DBREF 6IZQ D 145 477 UNP Q86X55 CARM1_HUMAN 145 477 SEQRES 1 A 333 SER ALA VAL GLN TYR PHE GLN PHE TYR GLY TYR LEU SER SEQRES 2 A 333 GLN GLN GLN ASN MET MET GLN ASP TYR VAL ARG THR GLY SEQRES 3 A 333 THR TYR GLN ARG ALA ILE LEU GLN ASN HIS THR ASP PHE SEQRES 4 A 333 LYS ASP LYS ILE VAL LEU ASP VAL GLY CYS GLY SER GLY SEQRES 5 A 333 ILE LEU SER PHE PHE ALA ALA GLN ALA GLY ALA ARG LYS SEQRES 6 A 333 ILE TYR ALA VAL GLU ALA SER THR MET ALA GLN HIS ALA SEQRES 7 A 333 GLU VAL LEU VAL LYS SER ASN ASN LEU THR ASP ARG ILE SEQRES 8 A 333 VAL VAL ILE PRO GLY LYS VAL GLU GLU VAL SER LEU PRO SEQRES 9 A 333 GLU GLN VAL ASP ILE ILE ILE SER GLU PRO MET GLY TYR SEQRES 10 A 333 MET LEU PHE ASN GLU ARG MET LEU GLU SER TYR LEU HIS SEQRES 11 A 333 ALA LYS LYS TYR LEU LYS PRO SER GLY ASN MET PHE PRO SEQRES 12 A 333 THR ILE GLY ASP VAL HIS LEU ALA PRO PHE THR ASP GLU SEQRES 13 A 333 GLN LEU TYR MET GLU GLN PHE THR LYS ALA ASN PHE TRP SEQRES 14 A 333 TYR GLN PRO SER PHE HIS GLY VAL ASP LEU SER ALA LEU SEQRES 15 A 333 ARG GLY ALA ALA VAL ASP GLU TYR PHE ARG GLN PRO VAL SEQRES 16 A 333 VAL ASP THR PHE ASP ILE ARG ILE LEU MET ALA LYS SER SEQRES 17 A 333 VAL LYS TYR THR VAL ASN PHE LEU GLU ALA LYS GLU GLY SEQRES 18 A 333 ASP LEU HIS ARG ILE GLU ILE PRO PHE LYS PHE HIS MET SEQRES 19 A 333 LEU HIS SER GLY LEU VAL HIS GLY LEU ALA PHE TRP PHE SEQRES 20 A 333 ASP VAL ALA PHE ILE GLY SER ILE MET THR VAL TRP LEU SEQRES 21 A 333 SER THR ALA PRO THR GLU PRO LEU THR HIS TRP TYR GLN SEQRES 22 A 333 VAL ARG CYS LEU PHE GLN SER PRO LEU PHE ALA LYS ALA SEQRES 23 A 333 GLY ASP THR LEU SER GLY THR CYS LEU LEU ILE ALA ASN SEQRES 24 A 333 LYS ARG GLN SER TYR ASP ILE SER ILE VAL ALA GLN VAL SEQRES 25 A 333 ASP GLN THR GLY SER LYS SER SER ASN LEU LEU ASP LEU SEQRES 26 A 333 LYS ASN PRO PHE PHE ARG TYR THR SEQRES 1 B 333 SER ALA VAL GLN TYR PHE GLN PHE TYR GLY TYR LEU SER SEQRES 2 B 333 GLN GLN GLN ASN MET MET GLN ASP TYR VAL ARG THR GLY SEQRES 3 B 333 THR TYR GLN ARG ALA ILE LEU GLN ASN HIS THR ASP PHE SEQRES 4 B 333 LYS ASP LYS ILE VAL LEU ASP VAL GLY CYS GLY SER GLY SEQRES 5 B 333 ILE LEU SER PHE PHE ALA ALA GLN ALA GLY ALA ARG LYS SEQRES 6 B 333 ILE TYR ALA VAL GLU ALA SER THR MET ALA GLN HIS ALA SEQRES 7 B 333 GLU VAL LEU VAL LYS SER ASN ASN LEU THR ASP ARG ILE SEQRES 8 B 333 VAL VAL ILE PRO GLY LYS VAL GLU GLU VAL SER LEU PRO SEQRES 9 B 333 GLU GLN VAL ASP ILE ILE ILE SER GLU PRO MET GLY TYR SEQRES 10 B 333 MET LEU PHE ASN GLU ARG MET LEU GLU SER TYR LEU HIS SEQRES 11 B 333 ALA LYS LYS TYR LEU LYS PRO SER GLY ASN MET PHE PRO SEQRES 12 B 333 THR ILE GLY ASP VAL HIS LEU ALA PRO PHE THR ASP GLU SEQRES 13 B 333 GLN LEU TYR MET GLU GLN PHE THR LYS ALA ASN PHE TRP SEQRES 14 B 333 TYR GLN PRO SER PHE HIS GLY VAL ASP LEU SER ALA LEU SEQRES 15 B 333 ARG GLY ALA ALA VAL ASP GLU TYR PHE ARG GLN PRO VAL SEQRES 16 B 333 VAL ASP THR PHE ASP ILE ARG ILE LEU MET ALA LYS SER SEQRES 17 B 333 VAL LYS TYR THR VAL ASN PHE LEU GLU ALA LYS GLU GLY SEQRES 18 B 333 ASP LEU HIS ARG ILE GLU ILE PRO PHE LYS PHE HIS MET SEQRES 19 B 333 LEU HIS SER GLY LEU VAL HIS GLY LEU ALA PHE TRP PHE SEQRES 20 B 333 ASP VAL ALA PHE ILE GLY SER ILE MET THR VAL TRP LEU SEQRES 21 B 333 SER THR ALA PRO THR GLU PRO LEU THR HIS TRP TYR GLN SEQRES 22 B 333 VAL ARG CYS LEU PHE GLN SER PRO LEU PHE ALA LYS ALA SEQRES 23 B 333 GLY ASP THR LEU SER GLY THR CYS LEU LEU ILE ALA ASN SEQRES 24 B 333 LYS ARG GLN SER TYR ASP ILE SER ILE VAL ALA GLN VAL SEQRES 25 B 333 ASP GLN THR GLY SER LYS SER SER ASN LEU LEU ASP LEU SEQRES 26 B 333 LYS ASN PRO PHE PHE ARG TYR THR SEQRES 1 C 333 SER ALA VAL GLN TYR PHE GLN PHE TYR GLY TYR LEU SER SEQRES 2 C 333 GLN GLN GLN ASN MET MET GLN ASP TYR VAL ARG THR GLY SEQRES 3 C 333 THR TYR GLN ARG ALA ILE LEU GLN ASN HIS THR ASP PHE SEQRES 4 C 333 LYS ASP LYS ILE VAL LEU ASP VAL GLY CYS GLY SER GLY SEQRES 5 C 333 ILE LEU SER PHE PHE ALA ALA GLN ALA GLY ALA ARG LYS SEQRES 6 C 333 ILE TYR ALA VAL GLU ALA SER THR MET ALA GLN HIS ALA SEQRES 7 C 333 GLU VAL LEU VAL LYS SER ASN ASN LEU THR ASP ARG ILE SEQRES 8 C 333 VAL VAL ILE PRO GLY LYS VAL GLU GLU VAL SER LEU PRO SEQRES 9 C 333 GLU GLN VAL ASP ILE ILE ILE SER GLU PRO MET GLY TYR SEQRES 10 C 333 MET LEU PHE ASN GLU ARG MET LEU GLU SER TYR LEU HIS SEQRES 11 C 333 ALA LYS LYS TYR LEU LYS PRO SER GLY ASN MET PHE PRO SEQRES 12 C 333 THR ILE GLY ASP VAL HIS LEU ALA PRO PHE THR ASP GLU SEQRES 13 C 333 GLN LEU TYR MET GLU GLN PHE THR LYS ALA ASN PHE TRP SEQRES 14 C 333 TYR GLN PRO SER PHE HIS GLY VAL ASP LEU SER ALA LEU SEQRES 15 C 333 ARG GLY ALA ALA VAL ASP GLU TYR PHE ARG GLN PRO VAL SEQRES 16 C 333 VAL ASP THR PHE ASP ILE ARG ILE LEU MET ALA LYS SER SEQRES 17 C 333 VAL LYS TYR THR VAL ASN PHE LEU GLU ALA LYS GLU GLY SEQRES 18 C 333 ASP LEU HIS ARG ILE GLU ILE PRO PHE LYS PHE HIS MET SEQRES 19 C 333 LEU HIS SER GLY LEU VAL HIS GLY LEU ALA PHE TRP PHE SEQRES 20 C 333 ASP VAL ALA PHE ILE GLY SER ILE MET THR VAL TRP LEU SEQRES 21 C 333 SER THR ALA PRO THR GLU PRO LEU THR HIS TRP TYR GLN SEQRES 22 C 333 VAL ARG CYS LEU PHE GLN SER PRO LEU PHE ALA LYS ALA SEQRES 23 C 333 GLY ASP THR LEU SER GLY THR CYS LEU LEU ILE ALA ASN SEQRES 24 C 333 LYS ARG GLN SER TYR ASP ILE SER ILE VAL ALA GLN VAL SEQRES 25 C 333 ASP GLN THR GLY SER LYS SER SER ASN LEU LEU ASP LEU SEQRES 26 C 333 LYS ASN PRO PHE PHE ARG TYR THR SEQRES 1 D 333 SER ALA VAL GLN TYR PHE GLN PHE TYR GLY TYR LEU SER SEQRES 2 D 333 GLN GLN GLN ASN MET MET GLN ASP TYR VAL ARG THR GLY SEQRES 3 D 333 THR TYR GLN ARG ALA ILE LEU GLN ASN HIS THR ASP PHE SEQRES 4 D 333 LYS ASP LYS ILE VAL LEU ASP VAL GLY CYS GLY SER GLY SEQRES 5 D 333 ILE LEU SER PHE PHE ALA ALA GLN ALA GLY ALA ARG LYS SEQRES 6 D 333 ILE TYR ALA VAL GLU ALA SER THR MET ALA GLN HIS ALA SEQRES 7 D 333 GLU VAL LEU VAL LYS SER ASN ASN LEU THR ASP ARG ILE SEQRES 8 D 333 VAL VAL ILE PRO GLY LYS VAL GLU GLU VAL SER LEU PRO SEQRES 9 D 333 GLU GLN VAL ASP ILE ILE ILE SER GLU PRO MET GLY TYR SEQRES 10 D 333 MET LEU PHE ASN GLU ARG MET LEU GLU SER TYR LEU HIS SEQRES 11 D 333 ALA LYS LYS TYR LEU LYS PRO SER GLY ASN MET PHE PRO SEQRES 12 D 333 THR ILE GLY ASP VAL HIS LEU ALA PRO PHE THR ASP GLU SEQRES 13 D 333 GLN LEU TYR MET GLU GLN PHE THR LYS ALA ASN PHE TRP SEQRES 14 D 333 TYR GLN PRO SER PHE HIS GLY VAL ASP LEU SER ALA LEU SEQRES 15 D 333 ARG GLY ALA ALA VAL ASP GLU TYR PHE ARG GLN PRO VAL SEQRES 16 D 333 VAL ASP THR PHE ASP ILE ARG ILE LEU MET ALA LYS SER SEQRES 17 D 333 VAL LYS TYR THR VAL ASN PHE LEU GLU ALA LYS GLU GLY SEQRES 18 D 333 ASP LEU HIS ARG ILE GLU ILE PRO PHE LYS PHE HIS MET SEQRES 19 D 333 LEU HIS SER GLY LEU VAL HIS GLY LEU ALA PHE TRP PHE SEQRES 20 D 333 ASP VAL ALA PHE ILE GLY SER ILE MET THR VAL TRP LEU SEQRES 21 D 333 SER THR ALA PRO THR GLU PRO LEU THR HIS TRP TYR GLN SEQRES 22 D 333 VAL ARG CYS LEU PHE GLN SER PRO LEU PHE ALA LYS ALA SEQRES 23 D 333 GLY ASP THR LEU SER GLY THR CYS LEU LEU ILE ALA ASN SEQRES 24 D 333 LYS ARG GLN SER TYR ASP ILE SER ILE VAL ALA GLN VAL SEQRES 25 D 333 ASP GLN THR GLY SER LYS SER SER ASN LEU LEU ASP LEU SEQRES 26 D 333 LYS ASN PRO PHE PHE ARG TYR THR HET XJ2 A 501 17 HETNAM XJ2 (2R)-1-(METHYLAMINO)-3-(1,3,4,5-TETRAHYDRO-2- HETNAM 2 XJ2 BENZAZEPIN-2-YL)PROPAN-2-OL FORMUL 5 XJ2 C14 H22 N2 O FORMUL 6 HOH *55(H2 O) HELIX 1 AA1 SER A 145 GLY A 154 1 10 HELIX 2 AA2 TYR A 155 GLN A 164 1 10 HELIX 3 AA3 ASP A 165 GLN A 178 1 14 HELIX 4 AA4 ASN A 179 PHE A 183 5 5 HELIX 5 AA5 GLY A 196 ALA A 205 1 10 HELIX 6 AA6 THR A 217 ASN A 229 1 13 HELIX 7 AA7 ARG A 267 ALA A 275 1 9 HELIX 8 AA8 ASP A 299 ASN A 311 1 13 HELIX 9 AA9 PHE A 312 TYR A 314 5 3 HELIX 10 AB1 SER A 317 VAL A 321 5 5 HELIX 11 AB2 LEU A 323 ALA A 325 5 3 HELIX 12 AB3 LEU A 326 ARG A 336 1 11 HELIX 13 AB4 ASP A 344 LEU A 348 5 5 HELIX 14 AB5 LYS A 363 LEU A 367 5 5 HELIX 15 AB6 GLN B 148 TYR B 153 1 6 HELIX 16 AB7 TYR B 155 GLN B 164 1 10 HELIX 17 AB8 ASP B 165 GLN B 178 1 14 HELIX 18 AB9 ASN B 179 PHE B 183 5 5 HELIX 19 AC1 GLY B 196 ALA B 205 1 10 HELIX 20 AC2 THR B 217 ASN B 229 1 13 HELIX 21 AC3 ARG B 267 ALA B 275 1 9 HELIX 22 AC4 ASP B 299 ASN B 311 1 13 HELIX 23 AC5 LEU B 323 ALA B 325 5 3 HELIX 24 AC6 LEU B 326 ARG B 336 1 11 HELIX 25 AC7 ASP B 344 LEU B 348 5 5 HELIX 26 AC8 LYS B 363 LEU B 367 5 5 HELIX 27 AC9 ALA C 146 GLY C 154 1 9 HELIX 28 AD1 TYR C 155 GLN C 164 1 10 HELIX 29 AD2 ASP C 165 GLN C 178 1 14 HELIX 30 AD3 ASN C 179 PHE C 183 5 5 HELIX 31 AD4 GLY C 196 ALA C 205 1 10 HELIX 32 AD5 THR C 217 ASN C 229 1 13 HELIX 33 AD6 ARG C 267 ALA C 275 1 9 HELIX 34 AD7 ASP C 299 ASN C 311 1 13 HELIX 35 AD8 PHE C 312 GLN C 315 5 4 HELIX 36 AD9 SER C 317 VAL C 321 5 5 HELIX 37 AE1 LEU C 323 ALA C 325 5 3 HELIX 38 AE2 LEU C 326 PHE C 335 1 10 HELIX 39 AE3 ASP C 344 LEU C 348 5 5 HELIX 40 AE4 LYS C 363 LEU C 367 5 5 HELIX 41 AE5 VAL D 147 TYR D 153 1 7 HELIX 42 AE6 TYR D 155 GLN D 164 1 10 HELIX 43 AE7 ASP D 165 ASN D 179 1 15 HELIX 44 AE8 HIS D 180 PHE D 183 5 4 HELIX 45 AE9 GLY D 196 ALA D 205 1 10 HELIX 46 AF1 THR D 217 ASN D 229 1 13 HELIX 47 AF2 ARG D 267 ALA D 275 1 9 HELIX 48 AF3 ASP D 299 ASN D 311 1 13 HELIX 49 AF4 PHE D 312 GLN D 315 5 4 HELIX 50 AF5 GLY D 328 PHE D 335 1 8 HELIX 51 AF6 ASP D 344 LEU D 348 5 5 HELIX 52 AF7 LYS D 363 LEU D 367 5 5 SHEET 1 AA1 5 ILE A 235 PRO A 239 0 SHEET 2 AA1 5 LYS A 209 GLU A 214 1 N ILE A 210 O VAL A 236 SHEET 3 AA1 5 ILE A 187 VAL A 191 1 N ASP A 190 O TYR A 211 SHEET 4 AA1 5 VAL A 251 SER A 256 1 O ILE A 255 N LEU A 189 SHEET 5 AA1 5 LEU A 279 PHE A 286 1 O PHE A 286 N ILE A 254 SHEET 1 AA2 4 VAL A 353 ASN A 358 0 SHEET 2 AA2 4 ILE A 289 PHE A 297 -1 N GLY A 290 O VAL A 357 SHEET 3 AA2 4 GLY A 382 ILE A 396 -1 O TRP A 390 N HIS A 293 SHEET 4 AA2 4 THR A 401 SER A 405 -1 O VAL A 402 N PHE A 395 SHEET 1 AA3 6 VAL A 353 ASN A 358 0 SHEET 2 AA3 6 ILE A 289 PHE A 297 -1 N GLY A 290 O VAL A 357 SHEET 3 AA3 6 GLY A 382 ILE A 396 -1 O TRP A 390 N HIS A 293 SHEET 4 AA3 6 GLN A 417 ALA A 428 -1 O LEU A 426 N VAL A 384 SHEET 5 AA3 6 VAL A 339 ASP A 341 -1 N VAL A 339 O ARG A 419 SHEET 6 AA3 6 PHE A 473 PHE A 474 1 O PHE A 473 N VAL A 340 SHEET 1 AA4 4 ARG A 369 HIS A 377 0 SHEET 2 AA4 4 THR A 433 ALA A 442 -1 O LEU A 434 N PHE A 376 SHEET 3 AA4 4 TYR A 448 VAL A 456 -1 O SER A 451 N LEU A 439 SHEET 4 AA4 4 LYS A 462 ASP A 468 -1 O LEU A 467 N ILE A 450 SHEET 1 AA5 5 ILE B 235 PRO B 239 0 SHEET 2 AA5 5 LYS B 209 GLU B 214 1 N ALA B 212 O ILE B 238 SHEET 3 AA5 5 ILE B 187 VAL B 191 1 N ASP B 190 O TYR B 211 SHEET 4 AA5 5 VAL B 251 SER B 256 1 O ILE B 255 N LEU B 189 SHEET 5 AA5 5 LEU B 279 PHE B 286 1 O LYS B 280 N VAL B 251 SHEET 1 AA6 4 VAL B 353 ASN B 358 0 SHEET 2 AA6 4 ILE B 289 PHE B 297 -1 N GLY B 290 O VAL B 357 SHEET 3 AA6 4 GLY B 382 ILE B 396 -1 O ASP B 392 N ASP B 291 SHEET 4 AA6 4 THR B 401 SER B 405 -1 O VAL B 402 N PHE B 395 SHEET 1 AA7 6 VAL B 353 ASN B 358 0 SHEET 2 AA7 6 ILE B 289 PHE B 297 -1 N GLY B 290 O VAL B 357 SHEET 3 AA7 6 GLY B 382 ILE B 396 -1 O ASP B 392 N ASP B 291 SHEET 4 AA7 6 GLN B 417 ALA B 428 -1 O VAL B 418 N PHE B 389 SHEET 5 AA7 6 VAL B 339 ASP B 341 -1 N VAL B 339 O ARG B 419 SHEET 6 AA7 6 PHE B 473 PHE B 474 1 O PHE B 473 N VAL B 340 SHEET 1 AA8 4 ARG B 369 HIS B 377 0 SHEET 2 AA8 4 THR B 433 ALA B 442 -1 O LEU B 434 N PHE B 376 SHEET 3 AA8 4 TYR B 448 VAL B 456 -1 O SER B 451 N LEU B 439 SHEET 4 AA8 4 LYS B 462 ASP B 468 -1 O SER B 463 N ALA B 454 SHEET 1 AA9 5 ILE C 235 PRO C 239 0 SHEET 2 AA9 5 LYS C 209 GLU C 214 1 N ILE C 210 O VAL C 236 SHEET 3 AA9 5 ILE C 187 VAL C 191 1 N VAL C 188 O LYS C 209 SHEET 4 AA9 5 VAL C 251 SER C 256 1 O ILE C 255 N LEU C 189 SHEET 5 AA9 5 LEU C 279 PHE C 286 1 O PHE C 286 N ILE C 254 SHEET 1 AB1 4 VAL C 353 ASN C 358 0 SHEET 2 AB1 4 ILE C 289 PHE C 297 -1 N VAL C 292 O TYR C 355 SHEET 3 AB1 4 GLY C 382 ILE C 396 -1 O TRP C 390 N HIS C 293 SHEET 4 AB1 4 THR C 401 SER C 405 -1 O VAL C 402 N PHE C 395 SHEET 1 AB2 6 VAL C 353 ASN C 358 0 SHEET 2 AB2 6 ILE C 289 PHE C 297 -1 N VAL C 292 O TYR C 355 SHEET 3 AB2 6 GLY C 382 ILE C 396 -1 O TRP C 390 N HIS C 293 SHEET 4 AB2 6 GLN C 417 ALA C 428 -1 O LEU C 426 N VAL C 384 SHEET 5 AB2 6 VAL C 339 ASP C 341 -1 N VAL C 339 O ARG C 419 SHEET 6 AB2 6 PHE C 473 PHE C 474 1 O PHE C 473 N VAL C 340 SHEET 1 AB3 4 ARG C 369 HIS C 377 0 SHEET 2 AB3 4 THR C 433 ASN C 443 -1 O LEU C 440 N ILE C 370 SHEET 3 AB3 4 SER C 447 VAL C 456 -1 O ASP C 449 N ILE C 441 SHEET 4 AB3 4 SER C 461 ASP C 468 -1 O SER C 463 N ALA C 454 SHEET 1 AB4 5 ILE D 235 PRO D 239 0 SHEET 2 AB4 5 LYS D 209 GLU D 214 1 N ILE D 210 O VAL D 236 SHEET 3 AB4 5 ILE D 187 VAL D 191 1 N ASP D 190 O TYR D 211 SHEET 4 AB4 5 VAL D 251 SER D 256 1 O ILE D 255 N LEU D 189 SHEET 5 AB4 5 LEU D 279 PHE D 286 1 O PHE D 286 N ILE D 254 SHEET 1 AB5 4 VAL D 353 ASN D 358 0 SHEET 2 AB5 4 ILE D 289 PHE D 297 -1 N VAL D 292 O TYR D 355 SHEET 3 AB5 4 GLY D 382 ILE D 396 -1 O ASP D 392 N ASP D 291 SHEET 4 AB5 4 THR D 401 SER D 405 -1 O LEU D 404 N VAL D 393 SHEET 1 AB6 6 VAL D 353 ASN D 358 0 SHEET 2 AB6 6 ILE D 289 PHE D 297 -1 N VAL D 292 O TYR D 355 SHEET 3 AB6 6 GLY D 382 ILE D 396 -1 O ASP D 392 N ASP D 291 SHEET 4 AB6 6 GLN D 417 ALA D 428 -1 O LEU D 426 N VAL D 384 SHEET 5 AB6 6 VAL D 339 ASP D 341 -1 N VAL D 339 O ARG D 419 SHEET 6 AB6 6 PHE D 473 PHE D 474 1 O PHE D 473 N VAL D 340 SHEET 1 AB7 4 ARG D 369 HIS D 377 0 SHEET 2 AB7 4 THR D 433 ALA D 442 -1 O LEU D 434 N PHE D 376 SHEET 3 AB7 4 TYR D 448 VAL D 456 -1 O ASP D 449 N ILE D 441 SHEET 4 AB7 4 SER D 461 SER D 463 -1 O SER D 463 N ALA D 454 SHEET 1 AB8 4 ARG D 369 HIS D 377 0 SHEET 2 AB8 4 THR D 433 ALA D 442 -1 O LEU D 434 N PHE D 376 SHEET 3 AB8 4 TYR D 448 VAL D 456 -1 O ASP D 449 N ILE D 441 SHEET 4 AB8 4 LEU D 466 ASP D 468 -1 O LEU D 467 N ILE D 450 CISPEP 1 PHE A 286 PRO A 287 0 9.31 CISPEP 2 PHE B 286 PRO B 287 0 9.67 CISPEP 3 PHE C 286 PRO C 287 0 2.14 CISPEP 4 PHE D 286 PRO D 287 0 0.56 SITE 1 AC1 11 PHE A 152 TYR A 153 GLN A 158 MET A 162 SITE 2 AC1 11 GLU A 257 MET A 259 TYR A 261 GLU A 266 SITE 3 AC1 11 MET A 268 HIS A 414 TRP A 415 CRYST1 74.788 98.926 206.792 90.00 90.00 90.00 P 21 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013371 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010109 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004836 0.00000